Deeken, John F. http://orcid.org/0000-0001-8414-1553
Wang, Hongkun
Hartley, Marion
Cheema, Amrita K.
Smaglo, Brandon
Hwang, Jimmy J.
He, Aiwu Ruth
Weiner, Louis M.
Marshall, John L.
Giaccone, Giuseppe
Liu, Stephen
Luecht, Jim
Spiegel, Jay Y.
Pishvaian, Michael J.
Clinical trials referenced in this document:
Documents that mention this clinical trial
A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
https://doi.org/10.1007/s00280-018-3533-8
Funding for this research was provided by:
Ruesch Center for the Cure of Gastrointestinal Cancers
National Cancer Institute (P30CA051008)
National Institutes of Health (UL1TR001409)
Article History
Received: 4 December 2017
Accepted: 26 January 2018
First Online: 1 February 2018
Conflict of interest
: Author John Deeken declares he has no conflict of interest. Author Hongkun Wang declares she has no conflict of interest. Author Marion Hartley declares she has no conflict of interest. Author Amrita K. Cheema declares she has no conflict of interest. Author Brandon Smaglo declares he has no conflict of interest. Author Jimmy J. Hwang declares he has no conflict of interest. Author Aiwu Ruth He declares she has no conflict of interest. Author Louis M. Weiner declares he has no conflict of interest. Author John L. Marshall declares he has no conflict of interest. Author Giuseppe Giaccone declares he has no conflict of interest. Author Stephen Liu declares he has no conflict of interest. Author Jim Luecht declares he has no conflict of interest. Author Jay Y. Spiegel declares he has no conflict of interest. Author Michael J. Pishvaian declares he has no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.